Steven Stice

Company: ArunA Bio

Job title: Co-Founder & Chief Scientific Officer

Seminars:

Update on Cleared US FDA IND for Acute Ischemic Stroke Using Neural Stem Cell Derived EVs 11:00 am

AB126: A first-in-class EV Therapy for stroke and CNS diseases and designed to treat stroke patients with poor prognosis post-reperfusion: A high medical-need IND-cleared, with preliminary work underway for the first-in-human trial AB126 offers a novel, multi-target solution with a clear mechanisms or action that address inflammation, immune response and repair NEW DATA!Read more

day: Conference Day One

Biopharma Leaders Panel Discussion: Unlocking the Next Wave of Safe & Efficient Exosome-Based Therapeutics Towards Clinical & Commercial Reality 1:30 pm

This is your chance to hear from pioneering executive leaders from the exosome and extra-cellular vesicle community who will discuss their strategies, challenges, and future perspectives for exosome technology and clinically relevant therapeutic applications. What are the future opportunities, promising targets, and applications on the horizon for exosomes to achieve clinical success? What can we…Read more

day: Conference Day One